← Leaderboards
Michael W. Graner
University Of Colorado Denver
$2,952,043
Attributed
$5,904,086
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2013–22$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$5,904,086 · 4
By mechanism
R01$3,571,190 · 2
R33$1,909,882 · 1
R21$423,014 · 1
Top collaborators
- Thomas Anchordoquy9 shared
- Xiaoli Yu5 shared
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Thomas Anchordoquy$4,579,186
- Judith T Blaine$5,081,736
- Aleem Siddiqui$17,154,020
- Xiaoli Yu$1,166,448
- George S Eisenbarth$13,354,570
Others in their field
Top investigators on “Tissues”
- David Heimbrook · Leidos Biomedical Research, Inc.$346,311,904
- Lawrence Corey · Fred Hutchinson Cancer Center$230,011,824
- Larry Arthur$159,140,370
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Judith S. Currier · University Of California Los Angeles$138,805,403
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$138,805,403
Research focus
TissuesAntibodiesNanoparticleBloodBaseLipidsBindingCarbohydratesImmunoglobulin GPreparationCross ReactivityMolecularLigandsLiposomesIn VivoLiverImmunocompetentDrug Delivery SystemsBiodistributionEnvironmentLungHarvestCellsCell Line
Grant awards (14)
Development of Validation of Phage-Displayed Random Peptide Libraries Technologies for Rapid Isolation and Characterization of Extracellular Vesicles from Patients with Brain Tumors$641,621
R33 · FY2022 · MH · contact PI
Development of Validation of Phage-Displayed Random Peptide Libraries Technologies for Rapid Isolation and Characterization of Extracellular Vesicles from Patients with Brain Tumors$636,104
R33 · FY2021 · MH · contact PI
Exploiting an endogenous transcytotic pathway for oral drug delivery$472,274
R01 · FY2021 · GM
Development of Validation of Phage-Displayed Random Peptide Libraries Technologies for Rapid Isolation and Characterization of Extracellular Vesicles from Patients with Brain Tumors$632,157
R33 · FY2020 · MH · contact PI
Exploiting an endogenous transcytotic pathway for oral drug delivery$472,274
R01 · FY2020 · GM
Exploiting an endogenous transcytotic pathway for oral drug delivery$498,809
R01 · FY2019 · GM
Development of Validation of Phage-Displayed Random Peptide Libraries Technologies for Rapid Isolation and Characterization of Extracellular Vesicles from Patients with Brain Tumors$210,752
R21 · FY2019 · MH · contact PI
Exploiting an endogenous transcytotic pathway for oral drug delivery$96,970
R01 · FY2019 · GM
Exploiting an endogenous transcytotic pathway for oral drug delivery$498,808
R01 · FY2018 · GM
Development of Validation of Phage-Displayed Random Peptide Libraries Technologies for Rapid Isolation and Characterization of Extracellular Vesicles from Patients with Brain Tumors$212,262
R21 · FY2018 · MH · contact PI
Tumor-Homing Exosomes for Drug Delivery$388,750
R01 · FY2016 · EB
Tumor-Homing Exosomes for Drug Delivery$380,975
R01 · FY2015 · EB
Tumor-Homing Exosomes for Drug Delivery$375,976
R01 · FY2014 · EB
Tumor-Homing Exosomes for Drug Delivery$386,354
R01 · FY2013 · EB